Britney, Primary Wave and the premium for legacy

In February 2026 Britney Spears sold her catalogue to Primary Wave for an estimated ~$200m. It is the latest, and among the largest, examples of investor appetite for proven legacy names with durable, recognisable songs. The headline number will draw attention. The more useful exercise, for anyone underwriting or advising on deals of this kind, is to ask what that number is actually pricing.

Legacy catalogue valuation is not simply a function of fame. A superstar name generates noise: press coverage, comparables cited in the next negotiation, a sense that the asset class is proven. But the cash flows that justify a premium multiple come from something narrower and more mundane, a small number of songs that have already demonstrated they keep earning across formats, generations and use cases, decades after release.

What the premium is actually for

The market has learned to pay up for catalogues where the earnings base is concentrated in songs with a long, evidenced history of use: repeated sync placements, enduring radio and streaming presence, consistent demand from advertisers and film and television. That history is the closest thing this asset class has to a track record. It substitutes for the absence of a long public trading history and gives a buyer or lender something to underwrite against other than sentiment.

This is why deals involving recognisable global names tend to draw comparisons to trophy assets in other sectors. The label is not wrong, but it can mislead if it is taken to mean the whole catalogue behind the name commands the same multiple. In practice, value concentrates unevenly. A handful of songs typically carry a disproportionate share of durable income, while the remainder of a catalogue behaves more like a long tail: real, but far less predictable, and far less deserving of a premium multiple.

Separating the signal from the name

For lenders and investors assessing legacy catalogue valuation, the discipline is to look past the artist's profile and into the composition of earnings. Questions worth asking include how concentrated income is across the catalogue, how much of it derives from formats or territories with structural tailwinds versus ones in decline, and how much of the historical earnings pattern is genuinely repeatable rather than tied to a one-off cultural moment.

None of this is a comment on any specific catalogue's worth. Public sale prices, including the figure reported for this transaction, are useful data points precisely because they are rare and because the underlying detail, the royalty structure, the rights retained, the split between recorded and publishing income, is usually not disclosed. Treating a headline number as a benchmark multiple for the next negotiation, without that detail, is how noise gets mistaken for signal.

Deals like this one are good for the asset class. They confirm that capital continues to flow towards music rights and that legacy names retain commercial relevance well beyond their chart peak. But the lesson for buyers, lenders and advisers is the same one that applies whether the artist involved is a household name or not: durable value sits in the verifiable pattern of income behind specific songs, not in the size of the number attached to the artist above them.